Cabot Stock Price, News & Analysis (NYSE:CBT)

Cabot trades on the New York Stock Exchange (NYSE) under the ticker symbol "CBT."

Cabot declared a quarterly dividend on Friday, July 12th. Shareholders of record on Friday, August 30th will be paid a dividend of $0.35 per share on Friday, September 13th. This represents a $1.40 annualized dividend and a dividend yield of 3.21%. The ex-dividend date of this dividend is Thursday, August 29th. View Cabot's Dividend History.

Cabot declared that its Board of Directors has approved a share buyback plan on Monday, July 16th 2018, which allows the company to buyback $400,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization allows the company to purchase up to 10.3% of its stock through open market purchases. Stock buyback plans are generally a sign that the company's board believes its stock is undervalued.

Cabot Corp (NYSE:CBT) released its quarterly earnings results on Monday, August, 5th. The specialty chemicals company reported $1.00 EPS for the quarter, meeting the Zacks' consensus estimate of $1.00. The specialty chemicals company had revenue of $845 million for the quarter, compared to analyst estimates of $858.86 million. Cabot had a return on equity of 18.60% and a net margin of 6.49%. The company's quarterly revenue was down 1.1% compared to the same quarter last year. During the same period in the prior year, the business earned $1.06 EPS. View Cabot's Earnings History.

Cabot is scheduled to release their next quarterly earnings announcement on Monday, November 4th 2019. View Earnings Estimates for Cabot.

Cabot will be holding an earnings conference call on Monday, November 4th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

5 brokers have issued 12-month price objectives for Cabot's shares. Their predictions range from $40.00 to $45.00. On average, they expect Cabot's share price to reach $43.20 in the next year. This suggests that the stock has a possible downside of 1.0%. View Analyst Price Targets for Cabot.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cabot in the last year. There are currently 3 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Cabot.

Headlines about CBT stock have trended somewhat negative recently, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Cabot earned a news sentiment score of -1.9 on InfoTrie's scale. They also gave media coverage about the specialty chemicals company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock's share price in the near future. View News Stories for Cabot.

Cabot saw a drop in short interest during the month of September. As of September 30th, there was short interest totalling 689,500 shares, a drop of 7.2% from the August 30th total of 743,000 shares. Based on an average daily trading volume, of 339,500 shares, the short-interest ratio is currently 2.0 days. Approximately 1.2% of the company's shares are short sold. View Cabot's Current Options Chain.

Some companies that are related to Cabot include Versum Materials (VSM), Platform Specialty Products (PAH), Element Solutions (ESI), WD-40 (WDFC), Orion Engineered Carbons (OEC), Advanced Emissions Solutions (ADES), Flotek Industries (FTK), Pure Bioscience (PURE), HighCom Global Security (HCGS), GlyEco (GLYE), Artemis Therapeutics (ATMS) and Ener-Core (ENCR).

Based on aggregate information from My MarketBeat watchlists, some companies that other Cabot investors own include Broadcom (AVGO), JPMorgan Chase & Co. (JPM), Energy Transfer LP Unit (ET), Oracle (ORCL), Wells Fargo & Co (WFC), Adobe (ADBE), Gilead Sciences (GILD), AT&T (T), Micron Technology (MU) and Cisco Systems (CSCO).

Cabot's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Cambiar Investors LLC (0.10%), Envestnet Asset Management Inc. (0.07%), Pacer Advisors Inc. (0.04%), Biltmore Wealth Management LLC (0.03%), State of Alaska Department of Revenue (0.02%) and Nisa Investment Advisors LLC (0.02%). Company insiders that own Cabot stock include Brian A Berube, Gottberg Friedrich Von, Hobart Kalkstein, James Patrick Kelly, Michael M Morrow, Nicholas S Cross, Patrick M Prevost and Sean D Keohane. View Institutional Ownership Trends for Cabot.

CBT stock was sold by a variety of institutional investors in the last quarter, including Pacer Advisors Inc.. View Insider Buying and Selling for Cabot.

CBT stock was acquired by a variety of institutional investors in the last quarter, including Cambiar Investors LLC, Biltmore Wealth Management LLC, Ferguson Wellman Capital Management Inc., Envestnet Asset Management Inc., State of Alaska Department of Revenue, North Star Investment Management Corp. and Nisa Investment Advisors LLC. View Insider Buying and Selling for Cabot.

Shares of CBT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CBT stock can currently be purchased for approximately $43.62.

Cabot has a market capitalization of $2.52 billion and generates $3.24 billion in revenue each year. The specialty chemicals company earns $-113,000,000.00 in net income (profit) each year or $4.03 on an earnings per share basis. Cabot employs 4,600 workers across the globe.View Additional Information About Cabot.

The official website for Cabot is http://www.cabot-corp.com/.

Cabot's mailing address is TWO SEAPORT LANE SUITE 1300, BOSTON MA, 02210. The specialty chemicals company can be reached via phone at 617-345-0100 or via email at [email protected]